Faculty of Physical Therapy Cairo University
Giza, 12511, Egypt
NCT Number: NCT05275634
To investigate the effect of different carrier frequencies of interferential current on pressure pain threshold, neck disability, cervical range of motion and upper trapezius muscle activity when applied on upper trapezius chronic myofascial trigger points: Randomized Controlled Trial
Looking for future studies?
Notify Me18 year–29 year
All sexes
Interventional
Not applicable
Giza, 12511, Egypt
Interferential current (IFC) is a medium frequency current derived from the interference of two symmetrical, but asynchronous alternating currents ranged from 1 to 10 KHz. The two main currents resulting in a single interference current with properties uniquely different from the two original currents.The lesser current of the two original currents is termed the carrier frequency and the interference current is called the beat frequency. A specific beat frequency can be obtained from several possible interference currents as long as the difference between the original currents is the same. For electro pain modulation, IFC is commonly used form of electrotherapy. It has the advantage of reducing the skin impedance, deeper penetration into tissues and is perceived as more comfortable.
Myofascial pain syndrome (MPS) is a common form of chronic musculoskeletal pain that widely spread and contributing to a significant financial burden and job- related disability. It represents the most common disorder in patients with nonspecific chronic neck pain.The main characteristics of MPS include the presence of myofascial trigger points (MTrPs) which are defined as hyperirritable nodule in a taut band of skeletal muscle fibers which is palpable and tender during physical examination. Trigger points (TrPs) are usually seen in the upper fiber of trapezius. TrPs can be clinically classified as either active or latent. Active TrPs was defined as: MTrPs that refer pain during activity and during rest without any pressure. They prevent full muscle lengthening and induce their weakness. Latent TrPs was defined as: MTrPs that is painful only when palpated. Evidence on the effect of IFC on pain modulation is not confirmed up till now. This might be attributed to multiple factors such as limited number of studies, inappropriate use of the parameters or using single carrier frequency (4 KHz) in majority of studies and the physiological effects of all our modalities are dose dependent. Dose depends on details of parameters including frequency. For IFC, the carrier frequency of the current has been suggested as an important parameter to achieve the most effective hypoalgesic response. However, there remains no evidence to support the selection of one carrier frequency over another. Few studies were conducted to examine the effect of different carrier frequencies by comparing their individual effects. Further researches are needed to prove which carrier frequency is more effective in treatment. Therefore, this study will be conducted to compare the effect of different carrier frequencies of the IFC in the management of upper trapezius chronic TrPs.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard treatment will be (active cervical range of motion exercises, myofascial release to upper trapezius muscle and postural advices at home).
Interferential current treatment parameters will be as following; carrier frequency 2 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.
Interferential current treatment parameters will be as following; carrier frequency 4 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.
Interferential current treatment parameters will be as following; carrier frequency 8 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.
Interferential current intensity will not be raised.
Time frame: Immediately after the end of the treatment
Pressure pain threshold will be measured by digital pressure algometer
Time frame: 12 weeks following the end of the treatment
Pressure pain threshold will be measured by digital pressure algometer
Time frame: Immediately after the end of the treatment
Neck disability will be measured by Arabic neck disability index
Time frame: 12 weeks following the end of the treatment
Neck disability will be measured by Arabic neck disability index
Time frame: Immediately after the end of the treatment
Cervical range of motion will be measured by cervical range of motion device
Time frame: 12 weeks following the end of the treatment
Cervical range of motion will be measured by cervical range of motion device
Time frame: Immediately after the end of the treatment
Muscle activity will be measured by electromyography in the form of root mean square
Time frame: 12 weeks following the end of the treatment
Muscle activity will be measured by electromyography in the form of root mean square
Cairo University
Other
Effect of Different Carrier Frequencies of Interferential Current on Upper Trapezius Myofascial Trigger Points: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05415813
Upper Trapezius Trigger Points
Sialkot, Punjab Province, Pakistan
View Trial DetailsNCT05187468
Muscular Diseases, Musculoskeletal Diseases
Nicosia, Cyprus
View Trial DetailsNCT07260019
Non Specific Chronic Neck Pain, Upper Trapezius Trigger Points
View Trial DetailsNCT07058636
Brain Diseases, Central Nervous System Diseases
Ankara, Turkey (Türkiye)
View Trial Details